|Year : 2022 | Volume
| Issue : 1 | Page : 11
Prevalence of osteoporosis and osteopenia in people over 60 years in Iran: A systematic review and meta-analysis
Hassan Nourmohammadi1, Zahra Abdan2, Seyed Mohammad Amin Hashemipour3, Diana Sarokhani4, Mohsen Abdan4, Moloud Fakhri5, Ali Hasanpour Dehkordi6
1 Department of Internal Medicine, Shahid Mostafa Khomeini Hospital, Ilam, Iran
2 Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Young Researchers and Elites Club, Faculty of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran
4 Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
5 Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran
6 Social Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran
|Date of Submission||31-Oct-2020|
|Date of Acceptance||19-May-2021|
|Date of Web Publication||19-Jan-2022|
Ali Hasanpour Dehkordi
Social Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord
Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari
Source of Support: None, Conflict of Interest: None
Background: Osteoporosis in the elderly has dangerous complications, the most important of which are bone fractures and reduced quality of life in the elderly. The present study was aimed at estimating the prevalence of osteoporosis in Iranian elderly using systematic review and meta-analysis. Methods: This search was conducted using authentic Persian and English keywords in national and international databases including Scientific Information Database, Magiran, IranDoc, PubMed, Scopus, Cochrane, Embase, and Web of Sciencewith no time limit until 20.06.2020. Heterogeneity of studies was assessed using I2 index. Data were analyzed using STATA Ver. 15 software. Results: In 30 studies with a sample size of 13,347 people, the prevalence of osteoporosis and low bone density in people over 60 years in Iran were 34% (95% CI: 27%, 42%) and 47% (95% CI: 41%, 53%), respectively. We also found that 34% of women and 41% of men over the age of 60 suffer from osteoporosis. Prevalence of osteoporosis was in lumbar bone 23% (95% CI: 20%, 26%), spine 25% (95% CI: 19%, 31%), hip 35% (95% CI: 7%, 62%), and femur 23% (95% CI: 15%, 31%). Prevalence of low bone density was in lumbar bone 41% (95% CI: 19%, 63%), spine 30% (95% CI: 15%, 46%), and femur 35% (95% CI: 21%, 48%). Conclusion: The prevalence of low bone density in people over 60 years is higher than the prevalence of osteoporosis in them. About one-third of Iranian elderly people suffer from osteoporosis, but about half of them have low bone density.
Keywords: Age-related bone loss, elderly, Iran, low bone density, metabolic bone disease, osteopenia, osteoporoses, osteoporosis
|How to cite this article:|
Nourmohammadi H, Abdan Z, Amin Hashemipour SM, Sarokhani D, Abdan M, Fakhri M, Dehkordi AH. Prevalence of osteoporosis and osteopenia in people over 60 years in Iran: A systematic review and meta-analysis. Int J Prev Med 2022;13:11
|How to cite this URL:|
Nourmohammadi H, Abdan Z, Amin Hashemipour SM, Sarokhani D, Abdan M, Fakhri M, Dehkordi AH. Prevalence of osteoporosis and osteopenia in people over 60 years in Iran: A systematic review and meta-analysis. Int J Prev Med [serial online] 2022 [cited 2022 May 24];13:11. Available from: https://www.ijpvmjournal.net/text.asp?2022/13/1/11/335964
| Introduction|| |
The phenomenon of aging in the global population has led to an increase in the population of people aged 60 years and older due to the reduction in the mortality rate resulting from advances in medical sciences, health, education and, consequently, the increase in life expectancy and longevity. As defined by the World Health Organization, they are called elderly people,,, According to this definition, more than 600 million people in the world are elderly, and this figure will double by 2025, and by 2050, it will reach over 2 billion people., In Iran, surveys and statistical indicators indicate the rapid growth of the elderly population. The population of the elderly is expected to increase by 10.5% by 2025.
As the aging population grows, people are at risk of a variety of physical, social, economic well-being problems, and chronic diseases such as diabetes, cardiovascular, joints, and bones diseases., Metabolic bone disorder is an abnormality of bones indicated by reduced bone mass and high risk of fractures. Several lines of evidence have demonstrated that the local bone tissue renin-angiotensin system is directly involved in bone metabolism and influences the bone health. Osteoporosis is one of the most important health threats to the elderly community, as more than half of all women over 45 and 90% of women over the age of 75 are afflicted with osteoporosis., This silent disease is often preventable and curable and sometimes leads to disability, and due to the reduced bone mass and bone loss, it is the major cause of fractures and increases mortality, disability, and medical costs.,, Osteoporosis is a major public health problem in the world, and fracture is the most important consequence of this disease. Among various types of fractures, hip fracture, especially in the elderly, is one of the major threats to human societies. Pain, reduced physical activity, depression, disability, medical problems, psychological problems, and social isolation are other complications of the chronic disease worldwide. These complications impair the daily activities of the elderly and lead to a decline in their quality of life.,,, Therefore, the need for a meta-analysis seems necessary. A systematic review of all documentation and their combinations can provide comprehensive and accurate statistics on the prevalence of osteoporosis in Iranian elderly people.
| Methods|| |
Study Protocol: The present study used systematic review and meta-analysis methods and aimed at estimating the prevalence of osteoporosis and osteopenia in people over 60 years in Iran. This study made use of the PRISMA protocol which is used for systematic review and meta-analysis studies.
Statistical Population: Participants in the selected studies were people over 60 years.
Study outcomes Primary outcomes: The main outcome of this study is the prevalence of osteoporosis and low bone density in people over 60 years in Iran.
Secondary outcomes: The subsidiary outcomes of this meta-analysis were the prevalence of osteoporosis and low bone density in different parts of the elderly (Femur, hip, lumbar, spine), as well as the prevalence of osteoporosis in men and women of different ages.
Search strategy: The present study is a systematic review and meta-analysis, which examines the prevalence of osteoporosis and osteopenia in people over 60 years in Iran. To obtain related articles in Persian and English, internal databases: Scientific Information Database, Magiran, IranDoc, and international databases: PubMed, Scopus, Cochrane, Embase, Web of Science were searched independently by two researchers using Persian keywords and their English equivalent (“Iran,” “Meta-analysis,” “Elderly,” “Osteopenia,” “Osteoporosis”). In order to finalize the search, keywords were also searched in the Google Scholar search engine without time limit until 20.06.2020. It should be noted that a combination of keywords was also searched using “OR, AND” operators.
Inclusion and exclusion criteria
All studies that reported the prevalence of osteoporosis and osteopenia in people over 60 years in Iran entered the study. There were no language or temporal limitations on the selection of studies. However, there was a location limitation and only studies on Iranian elderly were reviewed. The criteria for measuring osteoporosis and bone mineral density were the same in all articles. Osteopenia is a term to define bone density that is not normal but also not as low as osteoporosis. By definition from the WHO osteopenia is defined by bone densitometry as a T score -1 to -2.5. Osteoporosis, according to WHO definition, is when the bone mass density is above the standard deviation of more than 2.5 below the average value of young adults (T score < 2.5).
Studies have survey at the prevalence of osteoporosis and low bone density in people under 60 years of age; studies conducted outside Iran; studies have reported osteoporosis and low bone density as mean scores; studies have examined the effect of a drug or intervention on osteoporosis or low bone density in the elderly; studies that were of low quality in the qualitative evaluation stage; and studies that not mention the number of samples or the prevalence of osteoporosis.
Qualitative evaluation of the studies
In order to assess the quality of the studies, STROBE was used as the standard checklist. This checklist contains 22 items that cover different parts of a report (sampling, measurement of variables, study objectives, and statistical analysis). Depending on the type of study, all of which were descriptive-analytical and cross-sectional, we used different items on the Strobe checklist. Therefore, sections related to cohort or case-control studies were not used. One point was given to each item and some other items that were more important to us had more points. Articles that scored below 15 were removed from the meta-analysis process.
To reduce reporting bias and error in data collection, two researchers independently extracted data from articles and entered the extracted data into a checklist containing the following items: name of first author, study title, sample size, year of publication, year of study, place of study, age group, prevalence of osteoporosis in male, prevalence of osteoporosis in female, number of male, number of female, and prevalence of osteoporosis and osteopenia in skeletal sites including: lumbar, spine, hip, femur.
Definition of keywords
Osteoporosis: Osteoporosis is a skeletal condition characterized by decreased density (mass/volume) of normally mineralized bone. The reduced bone density leads to decreased mechanical strength, thus making the skeleton more likely to fracture. Postmenopausal osteoporosis (Type I) and age-related osteoporosis (Type II) are the most common primary forms of bone loss seen in clinical practice. Secondary causes of osteoporosis include hypercortisolism, hyperthyroidism, hyperparathyroidism, alcohol abuse, and immobilization.
Osteopenia: Osteopenia is a term to define bone density that is not normal but also not as low as osteoporosis. By definition from the World Health Organization, osteopenia is defined by bone densitometry as a T score -1 to -2.5.
Elderly: Ageing, an inevitable process, is commonly measured by chronological age and, as a convention, a person aged 65 years or more is often referred to as “elderly.”
To analyze and combine the results of various studies, the prevalence of osteoporosis in each study was considered as a probability of binomial distribution and its variance was calculated by binomial distribution. Heterogeneity of studies was investigated using Q-test and I square (I2). Regarding the heterogeneity of the studies, the random effect model was used to combine the results of various studies. Meta-regression was used to investigate the relationship between the prevalence of osteoporosis in the elderly and the number of samples and years of study. The data were analyzed using STATA Ver. 15 and the significance level of the test was considered 0.05.
| Results|| |
Study Selection Process: At the first stage of the search, 460 articles were found, and after reviewing the titles of articles, 195 duplicate and overlapping articles were deleted and 265 articles remained. In total, 190 articles were removed due to noncompliance with the criteria, the extract of 75 potentially related articles were reviewed, and 45 articles were excluded due to lack of access to the full text of the article. Finally, 30 appropriate papers were selected to enter the meta-analysis stage [Figure 1].
|Figure 1: A flowchart of studies into the process of systematic review and meta-analysis|
Click here to view
In 30 reviewed articles with a sample size of 13,347 people, the prevalence of osteoporosis in over 60 years in Iran was 34% (95%CI: 27–42%). The lowest and highest prevalence of osteoporosis in the elderly were found in the study of Cheraghi (8%) and Javad-Mousavi (83.3%). Considering the heterogeneity of studies, the confidence interval for each study based on the random effects model is presented in [Figure 2] and [Table 1].
|Figure 2: The prevalence of osteoporosis in Iranian elderly (95% CI) in terms of the author's name and years of research based on the random effects model. The midpoint of each section reveals the prevalence of elderly osteoporosis in each study. The lozenge shape shows the prevalence of osteoporosis in Iranian elderly for all the studies|
Click here to view
|Table 1: Specifications of articles which entered into the meta-analysis process|
Click here to view
As shown in [Figure 2] and [Figure 3], the prevalence of osteoporosis and low bone density in people over 60 years in Iran were 34% (95% CI: 27, 42%) and 47% (95%CI: 41, 53%) respectively. The prevalence of low bone density is higher than the prevalence of osteoporosis, so that about one-third of the Iranian elderly suffer from osteoporosis, but about half of them have low bone density. We also found that 34% of Iranian women and 41% of men over the age of 60 suffer from osteoporosis. According to the results, the prevalence of osteoporosis is higher in men than women [Table 2].
|Figure 3: The prevalence of low osteopenia in Iranian elderly (95% CI) in Iran based on the author's name and years of research based on the random effects model. The midpoint of each section reveals the prevalence of low osteopenia in the elderly in each study. The lozenge shape shows the prevalence of low Osteopenia in Iranian elderly for all studies|
Click here to view
In the analysis performed according to the age group of the subjects, the prevalence of osteoporosis in the age group of 60–64 years was 19% (95% CI: 15, 24%), 65–69 years 41% (95% CI: 33, 48%), 70–74 years 35% (95% CI: 18, 52%), and 75–79 years 41% (95% CI: 34, 47%). Also, the lowest prevalence of osteoporosis was in the age group of 60–64 years (19%) and the highest was in the age groups of 65–69 years and 75–79 years (41%). The prevalence of osteoporosis and low bone density also vary in different parts of the body. The prevalence of osteoporosis in lumbar bone 23% (95% CI: 20, 26%), spine 25% (95% CI: 19, 31%), hip 35% (95% CI: 7, 62%), and femur was 23% (95% CI: 15, 31%). The prevalence of low bone density in lumbar bone 41% (95% CI: 19, 63%), spine 30% (95% CI: 15, 46%), and femur was 35% (95% CI: 21, 48%). In lumbar, spine, and femur bones, the prevalence of low bone density was higher than the prevalence of osteoporosis [Table 2].
| Discussion|| |
The study was performed to investigate the prevalence of osteoporosis and low bone density in people over 60 years in Iran. Since the elderly are one of the most vulnerable groups of this disease, the need for such a study seems necessary and can be a basis for health care decisions. In 30 studies with a sample size of 13,347 people, the prevalence of osteoporosis in people over 60 years 34% (95% CI: 27, 42%) and the prevalence of low bone density was 47% (95% CI: 41, 53%).
Hemmati et al.'s study estimated the prevalence of osteoporosis and osteopenia in postmenopausal women to be 32 and 51%, respectively. The results of this study are consistent with the results of the current meta-analysis. This shows that in Iran, the prevalence of osteopenia in the elderly is lower than postmenopausal women, but the prevalence of osteoporosis in the elderly is higher than postmenopausal women. In addition, in the meta-analysis of Hemmati et al., results show that the highest prevalence of osteoporosis was reported in the lumbar (32%) and the lowest prevalence of osteoporosis in the spine and hip (21%), which is not consistent with the results of our study.
The results of Doosti Irani study show that the prevalence of osteoporosis in lumbar was 17% and the prevalence of osteopenia was 35%. This study shows that the prevalence of osteopenia in Iranians people is higher than the prevalence of osteoporosis in them, which is consistent with the results of our study, and this is a risk factor or alarm to increase the prevalence of osteoporosis in Iran.
Since about 25% of the Canadian population will be over 65 by 2041, it is estimated that osteoporosis will increase in the next few decades. In the study of England in 2010, we found that the prevalence of osteoporosis in the elderly was 72% and the prevalence of low bone density was 43%, and the number of elderly people in the study was 199 (113 males and 86 males). In a study in Brazil, 73 patients over 65 years of age, hip fracture ratio of women to men was 3.3 to 1. In a study by D.K. Chin in South Korea (2005), 759 elderly people (422 women and 337 men) with an average age of 62.55 years were evaluated. The prevalence of osteoporosis was 25.55% (51.3% for women and 14.5% for men) and low bone density (41.1% for women and 46.1 for men). In these studies, the prevalence of osteoporosis in elderly women is higher than that of the elderly, which is not consistent with the results of our study. Planning short and simple educational programs has a great impact on the control of the disease and its complications by the patient.
The prevalence of osteoporosis was reported to be 68.7% of women aged 65–74 in Chuncheon. In a study by Jang et al. (2006) on 362 elderly Dutch women, the prevalence of osteoporosis in women aged 74–75 was 67.5% in 75 years old and older women. The prevalence of osteoporosis in the elderly was higher in our studies than in our study.
The prevalence of osteoporosis in the elderly was 23% in the lumbar region, 25% in spine, 23% in femur neck, and 35% in hip joint. The prevalence of lower osteopenia was 41% in the lumbar region, 30% in the spine, and 35% in the femur neck. In Iranian elderly, the prevalence of osteoporosis in the hip area is higher than other areas and prevalence of osteopenia in the Lumbar is higher than other areas. In a study by Rahnavard et al., 70% of women and 50% of men were observed with hip osteoporosis and osteopenia. In addition, the prevalence of osteoporosis in the spine in Korean women aged 60–69 years was 62.2% and in women aged 70–79 was 88.9%. These figures were 35.8 and 88.4% for the hip area. It can be observed that the prevalence of osteoporosis in the spine and hip of the Korean elderly is significantly higher than that of the Iranian elderly. In a UK study on 199 elderly, the prevalence of osteoporosis in the forearm was 14%, lumbar spine 8.5%, and proximal femur 8.2%.
The prevalence of osteoporosis in Iranian elderly was also determined by the age group of the subjects. The prevalence of osteoporosis in the elderly is 60–64 years old, 19% (95% CI: 15–24%), the elderly is 65–69 years old, 41% (95% CI: 33–48%), the elderly is 70–74 years old, 35% (95% CI: 18–52%), and the elderly is 75–79 years old, 41% (95% CI: 34–47%). In a study done by Mojibian et al. among elderly women in the age group of 60–69 in Yazd, the prevalence of osteoporosis was 51.4% and osteopenia was 22.7%, and in the age group of 70 years and above; these values were 44.3 and 52.5%. In a study among Saudi women, the prevalence of osteoporosis in women aged 60–69 was 62% and in the 70–79 years old, elderly was 73.8%. The prevalence of osteoporosis in Saudi elderly seems to be higher than Iranian elderly.
Regarding the generalization of the results of this study to the whole Iranian elderly, given that the number of samples varied in different regions and in some regions or provinces of Iran there was no study in this field, and in contrast, in some areas of studies or other provinces more done. Therefore, studies have not been distributed uniformly in Iran. However, if the prevalence of osteoporosis in the whole of the Iranian elderly is similar, the outcome of this study could be generalized to the whole country because it can be assumed that these 30 studies with a sample of 13,347 people were randomly selected from among the elderly in Iran and can be generalized to the whole country by the result of this study. If the assumption is not correct, the result obtained from this study cannot be generalized to the whole country and stratify sampling should be used. The sample size in each study is proportional to the population of the elderly of the same province. It would have been possible to provide a more accurate estimate of the prevalence of osteoporosis in Iranian elderly people. Of course, according to available data in Iran, it is not possible to estimate the prevalence of osteoporosis in Iranian elderly by categorical sampling method. The best and most economical method for estimating the prevalence of osteoporosis in Iranian elderly is the same method of meta-analysis.
Limitations of study
The insufficient information of some articles, lack of uniform distribution of studies in various regions of Iran, and many studies did not investigate the prevalence of osteoporosis and low osteopenia in all parts of the elderly. This estimate of the prevalence of osteoporosis and low bone density in Iran may be different from the actual rate of prevalence of osteoporosis and low bone density in Iran because, first, no study has been conducted in some regions of Iran. Second, there has been no use of classification sampling to estimate the prevalence of osteoporosis. However, now this is perhaps the most accurate estimate of the prevalence of osteoporosis in Iran.
| Conclusions|| |
The prevalence of low bone density in people over 60 years is higher than the prevalence of osteoporosis in them. About one-third of Iranian elderly people suffer from osteoporosis, but about half of them have low bone density. On the other hand, the prevalence of osteoporosis is higher in men than women. The highest prevalence of osteoporosis was reported in hip and the highest prevalence of osteopenia was reported in lumbar. Due to the high prevalence of osteoporosis and bone fractures in the Iranian elderly, health policymakers should encourage people in elderly to exercise, and follow a healthy and balanced diet can get calcium, vitamin D, and other substances important nutrients help.
Ethical issues (including plagiarism, data fabrication, double publication) have been completely observed by the authors.
Financial support and sponsorship
Conflicts of interest
The authors declare that they have no conflict of interest regarding the contents of this article.
| References|| |
Aspray T. Health needs of elderly people. BMJ 1994;309:412.
Diana D, Parvareh M, Dehkordi A, Sayehmiri K, Moghimbeigi A. Prevalence of depression among Iranian elderly: Systematic review and meta-analysis. Iran J Psychiatry 2018;13:55-64.
Heydarnejad S, Hassanpour-Dehkordi A. The effect of an exercise program on the health-quality of life in older adults. Dan Med Bull 2010;57:113-7.
Tajvar M. Aged Care and Reviewing Various Aspects of Their Lives. Tehran: Nasl Farda Publications; 2004. p. 2.
WHO. World Health Organization launches new initiative to address the health needs of a rapidly ageing population. Cent Eur J Public Health 2004;12:210-6.
Deborah J, Cook D, Guyatt G, Adachi J, Clifton J, Griffith L, et al
. Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum 1993;36:750-6.
Nikpour S, Habibi A, Seiedoshohadai M, Haghani H. Relation between Quality of life and socio-demographic characteristics among older people in Tehran, Iran. Middle East J Age Aging 2007;4:25-30.
Hassanpour-Dehkordi A, Jalali A. Effect of progressive muscle relaxation on the fatigue and quality of life among Iranian aging persons. Acta Med Iran 2016;54:430-6.
Momenzadeh M, Khosravian M, VKS Lakkakula B. Potential of renin-angiotensin system inhibition to improve metabolic bone disorders. J Nephropharmacol 2021;10:e16.
Habibi A, Nikpour S, Seiedoshohadaei M, Haghani H. Quality of life and status of physical functioning among elderly people in west region of Tehran: A cross-sectional survey. Iran J Nurs 2008;21:29-39.
Lindsay R. and Cosman F. Harrison's Principles of Internal Medicine: Osteoporosis. 18th
ed. The McGraw Hill; 2012:3131-6.
Bagheri P, Haghdoost A, Eshagh D, Halimi L, Vafaei Z, Farhang Nya M, et al
. Ultra analysis of prevalence of osteoporosis in Iranian women “A systematic review and Meta-analysis”. Iran J Endocrinol Metab 2011;13:315-25.
Consensus A. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
Larijani B, Soltani A, Pajouhi M, Bastan hagh MH, Mirfeizi SZ, Dashti R, et al
. Bone mineral density variation in 20-69 y/o population of Tehran/Iran. Iran South Med J 2002;5:41-9.
Morris R, Masud T. Measuring quality of life in osteoporosis. Age Ageing 2001;30:371-3.
Canbaz S, Sunter A, Dabak S, Peksen Y. The prevalence of chronic diseases and quality of life in elderly people in Samsun. Turk J Med Sci 2003;33:335-40.
Sturtridge W, Lentle B, Hanley D. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. CMAJ 1996;155:924-9.
Zamani B, Ebadi S, Ahmadvand A, Moosavai G. The frequency of osteoporosis in hip fracture following minor trauma and the resulting mortality rate and direct treatment costs in patients over 45 years old in Kashan Naghavi hospital during 2005-2007. Journal of Kerman University of Medical Sciences 2010;17:137-44.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al
. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1.
Delaney M, leboff M. Metabolic bone disease. In: Ruddy S, Haris E Jr, Sledge CB, editors. Kelleys Text Book of Rheumatology. 5th
ed. United states of America: WB Saunders Company; 2001. p. 1635-45.
Von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann Intern Med 2007;147:573-7.
Glaser D, Kaplan F. Osteoporosis. Definition and clinical presentation. Spine (Phila Pa 1976) 1997;22:12-6.
Karaguzel G, Holick M. Diagnosis and treatment of osteopenia. Rev Endocr Metab Disord 2010;11:237-51.
Organisation WH. Definition of an older or elderly person. WHO, Geneva, Switzerland, 2010.
Cheraghi P, Cheraghi Z, Bozorgmehr S. The Prevalence and risk factors of osteoporosis among the elderly in Hamadan province: A cross sectional study. Med J Islam Repub Iran 2018;32:111.
Javad-Mousavi A, Zavvareii F, Shirani F. Study of osteoporosis prevalence in men with chronic obstructive pulmonary disease. Razi Journal of Medical Sciences 2006;12:19-26.
Esmaeili Shahmirzadi S, Shojaeizadeh D, Azam K, Tol A. A survey on quality of life in the elderly with osteoporosis. J Health Syst Res 2013;8:1180-89.
Mojibian M, Owlia M, Beiki Bandarabadi O, Kochak Yazdi L. Osteoporosis in postmenopausal women. Iran J Surg 2006;14:71-8.
Aghaalikhani M, Taheri Tanjani P, Hosseinpour Azari A, Mousavi M, Rezapour M, Amin Y, et al
. Prevalence of osteoporosis among above 60 years old subjects referred to Ayatollah Taleghani hospital in Tehran and its relationship with age and sex. Scientific Journal of Ilam University of Medical Sciences 2012;20:315-25.
Mazloomy mahmoudabad S, Soltani T, Morowatisharifabad M, Fallahzadeh H. Activities of daily living and prevalence of chronic diseases among elderly people in Yazd. J TOLOO-E-BEHDASHT 2014;13:42-53.
Aghajanpoor M, Salari A, Karimifar M, Zamani A, Salesi M, Mottaghi P. Comparison of the prevalence of osteopenia and osteoporosis in diabetic postmenopausal women with nondiabetic women. J Isfahan Med School 2014;32:1-12.
Dana Siadat Z, Rahmani S, Mahmoudian S, Eshaghi S. Prevalence of osteoporosis risk factors and need to bone mineral density testing in patients with pathologic fractures: Esfahan Kashani hospital. Journal of Isfahan Medical School 2011;29:1-9.
Maddah M, Sharami S, Karandish M. Educational difference in the prevalence of osteoporosis in postmenopausal women: A study in northern Iran. BMC Public Health 2011;11:1-3.
Pourhashem Z, Bayani M, Noreddini G, Bijani A, Hosseini S. Prevalence of osteoporosis and its association with serum vitamin D level in older people in Amirkola, North of Iran. Caspian J Intern Med 2012;3:347-53.
Abbasi M, Zohal M, Atapour B, Yazdi Z. Prevalence of osteoporosis and its risk factors in men with COPD in Qazvin. Int J Chronic Dis 2016:1-6.
Mojibian M, Kochak Yazdi L, Pakdel S. Osteoporosis In Postmenopausal women In Yazd. Maturitas
Spinal Osteoporosis Rate in Patients With Typical Symptoms of Lumbar Canal Stenosis. Reza Salman Roghani, Poster 143, Page:S218.
Mobini M, Kashi Z, Bahar A, Taslimi F, Forghanizadeh J, Abdi R. Osteoporosis and osteoporotic fractures in postmenopausal women with type 2 diabetes compared with non diabetic cases. Iran J Diabetes Obesity 2012;4:68-73.
Rahnavard Z, Zolfaghari A, Hosseinnezhad M, Dastgerdi M, Valizade A. The incidence of osteoporotic hip fracture: Iranian multi-center osteoporosis study (IMOS) Res J Biol Sci 2009;4:171-3.
Shams M, Homayouni K, Hamidi A, Sadegholvad A, Omrani G. Leptin and bone mineral density in healthy postmenopausal Iranian women: A populationbased study. Int J Endocrinol Metab (IJEM) 2006;4:70-7.
Heidari B, Muhammadi A, Javadian Y, Bijani A, Hosseini R, Babaei M. Associated factors of bone mineral density and osteoporosis in elderly males. Int J Endocrinol Metab (IJEM) 2017;15:e39662.
Ebrahimpur M, Sharifi F, Nezhad F, Bagherzadeh M, Ostovar A, Shafiee G, et al
. Effect of diabetes on BMD and TBS values as determinants of bone health in the elderly: Bushehr elderly health program. J Diabetes Metab Disord 2019;18:99-106.
Hosseini S, Cumming R, Kheirkhah F, Nooreddini H, Baiani M, Mikanik iE, et al
. Cohort profile: The Amirkola health and ageing project (AHAP). Int J Epidemiol 2014;43:1393-400.
Hasani-Ranjbar S, Jafari-Adli S, Payab M, Qorbani M, Ahanjideh F, Keshtkar A, et al
. Association of osteoporosis with anthropometric measures in a representative sample of Iranian Adults: The Iranian multicenter osteoporosis study. Int J Prev Med 2019;10:157. [Full text]
Hemmati F, Sarokhani D, Sayehmiri K, Motadayen M. Prevalence of osteoporosis in postmenopausal women in Iran: A systematic review and meta-analysis. The Iranian Journal of Obstetrics, Gynecology and Infertility, 2018;21:90-102.
Honarvar B, Bagheri Lankarani K, Azadegan M, Khaksar E, Jafari F, Rahmani Fard T. The prevalence and predictors of sleep disturbance in the elderly: A population-based study in Shiraz, Iran. Shiraz E-Med J 2019;20:e88349.
Papadimitropoulos E, Coyte P, Josse R, Greenwood C. Current and projected rates of hip fracture in Canada. CMAJ 1997;157:1357-63.
Lingard EA, Mitchell SY, Francis RM, Rawlings D, Peaston R, Birrell FN, et al
. The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty. Age Ageing 2009;39:234-9.
Baudoin C, Fardellone P, Bean K, Ostertag-Ezembe A, Hervy F. Clinical outcomes and mortality after hip fracture. Bone 1996;18:149-57.
Chin DK, Park JY, Yoon YS, Kuh SU, Jin BH, Kim KS, et al
. Prevalence of osteoporosis in patients requiring spine surgery: Incidence and significance of osteoporosis in spine disease. Osteoporos Int 2007;18:1219-24.
Noghabi AAA, Zandi M, Mehran A, Alavian SM, Dehkordi AH. The effect of education on quality of life in patients under interferon therapy. Hepatitis Monthly 2010;10:218-22.
Jang N, Choi Y, Choi M, Kang S, Jeong J, Choi Y, et al
. Prevalence and associated factors of osteoporosis among postmenopausal women in Chuncheon: Hallym Aging Study (HAS). J Prev Med Public Health 2006;39:389-96.
Limpaphayom K, Taechakraichana N, Aisamrarn U, Bunyavejchevin S, Chaikittisilpa S, Poshyachinda M, et al
. Prevalence of osteopenia and osteoporosis in Thai women. Menopause 2001;8:65-9.
El Desouki M. Osteoporosis in postmenopausal Saudi women using dual X ray bone densitometry. Saudi Med J 2003;24:953-6.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2]